[AIDS and intravenous drug abuse]. 1990

C R Schuster, and R W Pickens
National Institute on Drug Abuse, Rockville, M.D. 20857.

The importance of intravenous drug-abuse as a vehicle of HIV and AIDS is evidenced on the basis of recent epidemiological data gathered in the USA. The rate of seropositivity among intravenous drug-addicts (whose total number i is close to one million) is estimated at more than 20 percent. Besides direct contamination, risks of contamination of sexual partners and their offspring can be evaluated from these figures. The programme developed by the National Institute on Drug Abuse against AIDS, aimed at that particular target population, is presented in its various aspects, including basic research, treatment and prevention.

UI MeSH Term Description Entries
D008297 Male Males
D009316 National Institutes of Health (U.S.) An operating division of the US Department of Health and Human Services. It is concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research. United States National Institutes of Health,National Institutes of Health
D010353 Patient Education as Topic The teaching or training of patients concerning their own health needs. Education of Patients,Education, Patient,Patient Education
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D005260 Female Females
D006266 Health Education Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis. Community Health Education,Education, Health,Education, Community Health,Health Education, Community
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

C R Schuster, and R W Pickens
July 1987, British journal of addiction,
C R Schuster, and R W Pickens
March 1987, The Medical journal of Australia,
C R Schuster, and R W Pickens
January 1987, British journal of addiction,
C R Schuster, and R W Pickens
January 1987, British journal of addiction,
C R Schuster, and R W Pickens
January 1987, Advances in alcohol & substance abuse,
C R Schuster, and R W Pickens
January 1988, Network (Research Triangle Park, N.C.),
C R Schuster, and R W Pickens
May 1988, The Journal of the Florida Medical Association,
C R Schuster, and R W Pickens
January 1988, NIDA research monograph,
C R Schuster, and R W Pickens
January 1988, Nursing times,
C R Schuster, and R W Pickens
December 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Copied contents to your clipboard!